MADISON, N.J., Feb. 5 /PRNewswire-FirstCall/ -- Wyeth (NYSE: WYE) today announced that its Board of Directors has elected Timothy P. Cost, 48, to the position of Senior Vice President, Corporate Affairs effective immediately. Mr. Cost replaces Marily H. Rhudy, 59, who has announced her plans to retire.
Prior to joining Wyeth, Mr. Cost was Executive Vice President, Corporate Affairs at ARAMARK since 2003. During his 27-year career, he has served in senior executive roles for several leading companies. He formerly was Senior Vice President of Corporate Affairs for Pharmacia and, prior to that, Vice President of Investor Relations and Corporate Intelligence for Bristol-Myers Squibb Company. He also served as Senior Vice President, Communications and Strategy for Centocor, Inc. Mr. Cost began his career with Kodak, holding a number of management positions with the company, including Director of Strategic Planning, Worldwide Operations and Vice President, Investor Relations.
Mr. Cost earned his undergraduate degree from Jacksonville University in Florida and holds an M.B.A. in Finance and Economics from the William E. Simon Graduate School of Business at the University of Rochester.
"I am pleased to have a leader of Tim's caliber joining the senior management team," says Bernard Poussot, President and Chief Executive Officer, Wyeth. "His extensive and broad experience, especially in the biotechnology and pharmaceutical sectors, will help us as we continue to deliver innovative new products and navigate the changing business environment."
Ms. Rhudy joined Wyeth in 1993 as Assistant Vice President, Professional Relations for Wyeth's pharmaceuticals division and held positions of increasing responsibility while building Wyeth's public affairs function. She was promoted to Vice President, Corporate Public Affairs, Wyeth in 1997 and Senior Vice President, Corporate Public Affairs, Wyeth in 2004. Before joining Wyeth, she was appointed by the President to the White House Health Care Professionals Task Force on Health Care Reform in 1993.
"Marily has built an outstanding public affairs team that has forged strong external relationships to raise the level of awareness of Wyeth's contributions to health care," says Mr. Poussot. "In addition, her team has partnered across the Wyeth divisions to resolve complex business and product issues and to help the Company achieve its business goals. We thank Marily for her many contributions to our business."
Wyeth is one of the world's largest research-driven pharmaceutical and health care products companies. It is a leader in the discovery, development, manufacturing and marketing of pharmaceuticals, vaccines, biotechnology products and non-prescription medicines that improve the quality of life for people worldwide. The Company's major divisions include Wyeth Pharmaceuticals, Wyeth Consumer Healthcare and Fort Dodge Animal Health.
Copyright©2008 PR Newswire.
All rights reserved